Skip to content

Clinical trials

Observational Coronary Artery Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Observational Clear all

1,708 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200010
20017
20029
200318
200419
200519
200641
200741
200860
200957
201086
201155
201269
201364
201478
201568
201692
201796
201883
201994
202093
202188
202291
202383
202489
202585
202677

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed844
Unknown status361
Recruiting220
Active, not recruiting80
Not yet recruiting78
Terminated64
Withdrawn39
Enrolling by invitation19
Suspended3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seung-Jung Park29
Seoul National University Hospital27
Abbott Medical Devices26
National Heart, Lung, and Blood Institute (NHLBI)25
Yonsei University25
China National Center for Cardiovascular Diseases24
Shanghai Zhongshan Hospital23
Fundación EPIC20
Assiut University18
Beijing Anzhen Hospital16

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease1,708
Cardiovascular Diseases153
Myocardial Ischemia148
Coronary Disease126
Atherosclerosis117
Myocardial Infarction109
Heart Diseases92
Acute Coronary Syndrome84
Angina Pectoris78
Diabetes Mellitus75

Trials

Showing 76 to 100 of 1,708. Each trial links to its page on Pharma Observatory.

1,608 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.